Status:
COMPLETED
The Effect of a Multi-intervention Program and Protein Food Sources on Preventing and Mitigating Sarcopenia
Lead Sponsor:
China Medical University Hospital
Conditions:
Sarcopenia
Dietary Exposure
Eligibility:
All Genders
60+ years
Phase:
NA
Brief Summary
Sarcopenia is characterized by loss of skeletal muscle mass and strength with advancing age. It is linked to an increased risk of falls, disability, length of hospitalization, poor quality of life, an...
Eligibility Criteria
Inclusion
- over the age of 60 from the free-living community
Exclusion
- Kidney patients, diabetics, cancer patients, moderate/severe cognitively impaired, disability, those who take any commercial protein nutritional supplements, those who are underweight, vegans, food allergy to dairy products and soy products
Key Trial Info
Start Date :
December 29 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2024
Estimated Enrollment :
86 Patients enrolled
Trial Details
Trial ID
NCT06173271
Start Date
December 29 2022
End Date
April 30 2024
Last Update
October 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yi-Chen Huang
Taichung, Baseline and Post Test of Intervention, Taiwan, 406040